Trial intelligence / Profile preview

AV2-DM Antiviral Spray for HPV Infected Cervix

NCT01654822Phase 2Unknown

Sponsor
Cesa Projects International
Start
Aug 2012
Primary completion
Dec 2012
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

A Phase 2 trial of AV2 in human papillomavirus infection, sponsored by Cesa Projects International. Status: unknown.

02

Drugs

AV2
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on NCT01654822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01654822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call